Healthcare
Nearly half of India not active enough, says Lancet; Why is it concerning?
Almost 50 per cent of adults in India engaged in insufficient levels of physical activity in 2022, according to a study published in The Lancet Global Health journal. Far more women in India (57 per cent) were found to be insufficiently physically active, compared to men (42 per cent), in line with trends across the South Asian region, the study found.
Experts take note of a clear shift in India's fitness & nutrition trends
The growing demand for nutritional guidance and fitness coaching is driven by increased awareness of lifestyle disorders and dietary habits. Social media has amplified this consciousness.
WHO warns alarming levels of physical inactivity among Indians, says women more physically inactive than men
A study in The Lancet Global Health highlights that nearly 50% of Indian adults are physically inactive, posing severe health risks. The study shows a significant rise in inactivity from 2000 to 2022, with women being more affected than men. City doctors attribute this to sedentary office work and poor diets. The lack of physical activity increases the risk of cardiovascular diseases, cancers, and psychological issues. Experts stress the need for regular exercise and healthier lifestyles to address this growing concern.
Norms soon on disposing of expired medicines
The document is in the final stages of completion. It will include procedures to be followed for disposal, collection, storage and transportation of expired and unused drugs. Improper disposal of medications that have crossed the expiry date mentioned on the label or not used by the individual for whom they were prescribed and purchased may be hazardous to public health, animal health and environment, officials said.
Diabetes management made easier: Your guide to a healthier lifestyle
Proactively collaborating with healthcare professionals for personalized strategies enhances diabetes management, leading to improved overall well-being and better health outcomes.
World's first epilepsy device fitted in 13 year old UK boy's skull; Here's how the device works
Oran Knowlson, a 13-year-old from England with severe epilepsy, has become the first person to trial a new device implanted in his skull to control seizures. The groundbreaking surgery, which took place at Great Ormond Street Hospital in London, has reduced Oran's seizures by 80%. The device, a Picostim neurotransmitter, aims to disrupt abnormal brain signals causing epilepsy. Oran's improved quality of life following the surgery has brought hope to others with treatment-resistant epilepsy.
Everstone to merge two healthcare companies, list combined firm
Everstone Capital, a Pan Asia private equity fund, is merging Translumina Therapeutics, a major cardiac stent maker in India, as part of a big-ticket IPO plan.
Gauhati Medical College Hospital successfully completes its first cadaver kidney transplant
Guwahati Medical College Hospital (GMCH) has successfully completed its first cadaver kidney transplant and is also planning liver transplants. Assam’s Chief Minister Himanta Biswa Sarma announced the milestone achievement at GMCH, highlighting the importance of organ donation and the success in the IVF center.
Delivery boxes unhealthy: Nutritionist calls out Swiggy and Zomato over plastic containers; Zomato CEO responds
Celebrity nutritionist Luke Coutinho recently called on food delivery platforms Swiggy and Zomato to switch to biodegradable, non-plastic containers for food packaging. Highlighting the health risks of using plastic, especially for hot foods, Coutinho's appeal emphasized the need for safer food delivery practices. Zomato CEO Deepinder Goyal responded positively, promising to highlight restaurants that use food-safe packaging, while Swiggy is yet to respond.
Govt's big push for forensic infrastructure enhancement with financial outlay at Rs 2254 cr
Prime Minister Narendra Modi-led Union Cabinet on Wednesday approved a new scheme 'Central Sector Scheme “National Forensic Infrastructure Enhancement Scheme” (N.F.l.E.S.)' with financial outlay at financial outlay of Rs.2254.43 crore for campuses, labs and enhancement of infrastructure.
Must Watch
Morgan Stanley PE Asia Fund invests ₹500 crore in Omega Hospitals
"With the increasing incidence of cancer in recent years, our mission is to deliver high-quality, full-service cancer care offerings in India. This partnership with Morgan Stanley PE Asia will help us accelerate this journey, and we are excited to build Omega Hospitals into India’s largest cancer care chain in the next few years," said Dr. Mohan Vamsy, Managing Director of Omega Hospitals.
Heatwaves: A reminder to focus on health as part of climate action
Heatwaves are affecting a huge proportion of India’s population with health problems, including heatstroke, dehydration and worsened chronic health conditions. With over 25,000 cases of heat stroke being reported since March, hospitals have witnessed a spike in heat-related illness cases, stretching already strained public health systems.
Expert panel to soon weigh plan to use generics for prescription drugs
An expert committee is set to discuss the feasibility of allowing generic substitutions for prescription drugs in India. The proposal has sparked a disagreement between the Indian Pharmaceutical Alliance (IPA) and the All India Drug Action Network (AIDAN). The IPA opposes the idea, arguing that it would lead to a surge of demand from trade channels, such as general pharmacy stores, which would not benefit patients.
Fortis, Apollo, Medanta, and Max lead the charge in bidding war for Jaypee Healthcare
Fortis Healthcare, Apollo Hospitals, Medanta, and Max Healthcare are among companies interested in acquiring Jaypee Healthcare, a subsidiary of Jaypee Infratech in Noida with a total debt of about Rs 1,000 crore.
Health Ministry issues interdepartmental referral guidelines for hospitals
The guidelines stress the need for a multi-disciplinary approach for patients with multiple co-morbidities and highlight the importance of training in high-quality patient care.
Bharat Bio's Rotavirus vaccine Rotavac may be unsafe for children: Study
A study found that Bharat Biotech's Rotavac vaccine used in the government's immunization program increases the risk of intussusception in infants, a condition where the intestine telescopes into itself, leading to potential serious consequences.
